Cantor raises NewAmsterdam Pharma stock price target to $61
AI Summary
Cantor raised its price target for NewAmsterdam Pharma to $61. The brief report does not state the previous target or explain the rationale for the increase.
Related Articles
ASX set to fall, AI stocks drive Wall Street higher
The Sydney Morning Herald —
Warsaw retains place in European ranking
Warsaw Business Journal —
Loot boxes, influencers, and addictive features face an EU crackdown
The Verge —
Oracle’s stock is totally misunderstood and should be a ‘go-to’ AI play, says this analyst
MarketWatch —
Ternium weighs more anti-dumping cases as steel snarls trade talks with US
Investing.com —
Makinde to Oyo Lawmakers: ‘Be careful of what you do to me, I remain Gov till May 2027’
Vanguard Nigeria —